Abstract:BACKGROUND & OBJECTIVE Ovarian carcinoma is leading cause of death in gynecologic malignancies. The survival rate cannot be improved after routine surgery, chemotherapy, and radiotherapy. Therefore biotherapy becomes the fourth treatment pattern for ovarian carcinoma. Adequate experimental models for the development of biologic therapeutic strategies are needed. Our purpose was to establish and compare two intraperitoneally transplanted human ovarian carcinoma models with human immune reconstitution in severe combined immunodeficient (SCID) mice. METHODS Six and ten C.B17/SCID mice were intraperitoneally injected with human ovarian adenocarcinoma SKOV3 and SKOV3.ip1 cells, respectively. Their biological, histological, and immunological features were compared. Ascites of the mice in SKOV3.ip1 group was injected into other six mice. All the 22 SCID mice were intraperitoneally injected with human peripheral blood lymphocytes (PBL) to establish immune reconstituted model. RESULTS The taken rates of the SKOV3 and SKOV3.ip1 groups were both 100%. The latent periods of tumor growth were 20-41 days and 22-30 days, respectively (P >0.05). While the mean survival time were 50-78 days and 32-43 days, respectively (P< 0.0001). 83.3% (5/6) of the mice injected with ascites of the mice in SKOV3.ip1 group successfully formed new tumor mass and ascites. Autopsy showed the tumors of the two models were widespread in pelvic cavity. The SKOV3.ip1 group also had 0.35-5.60 ml bloody ascites that was similar to the clinical behavior of most patients, while only 0.2 ml in one mice of SKOV3 group. Histological results showed the tumors of the two groups remained the characteristics of serous papillary adenocarcinoma of human ovary, and immunohistochemistry staining showed the ovarian associated antigen OC166-9 were both positive. Human IgG were detected in 72.7% (16/22) of the mice, and human CD4(+) and CD8(+) T cells were positive in 54.5% (12/22) of the mice. CONCLUSION The two intraperitoneally transplanted human ovarian carcinoma models had been established in human PBL reconstituted SCID mice. The SKOV3.ip1 model may be an ideal animal model for biotherapy research of ovarian carcinoma as it simulates the intraperitoneally disseminating behavior of human ovarian carcinoma in the patients with immune function, and it took relatively shorter time to be established.

Ovarian carcinoma SKOV3 cell line and nude mice model with transfecting unit point mutant gene in follicle stimulating hormone receptor

Effect of interleukin-7 gene transfection into ovarian carcinoma cell line SKOV3 in vitro and in vivo.

[Biologic Characteristics of Intraperitoneal Transplantation Model of Human Ovarian Carcinoma in Severe Combined Immunodeficiency Mice].

Development of Intraperitoneally Transplantated Human Ovarian Carcinoma Model with Immune Reconstruction in Severe Combined Immunodeficient Mice

Induction of Human Ovarian Carcinoma Cell Line SKVO-3apoptosis by Sirna Through Targeting to Survivin

Antitumor Efficacy Induced By Human Ovarian Cancer Cells Secreting Il-21 Alone Or Combination With Gm-Csf Cytokines In Nude Mice Model

Conversion of Peripheral CD4+ CD25- Naive T Cells to CD4+ CD25+ Regulatory T Cells by Ovarian Carcinoma Cell Supernatants

Clinicopathological and biological significance of aberrant activation of glycogen synthase kinase-3 in ovarian cancer.

Construction of human recombinant Oct3/4 eukaryotic expression vectors and their expression in ovarian cancer cells

Inhibitory Effect of STAT3 Silenced with RNAi on Growth of Human Ovarian Cancer SKOV3 Cell Transplanted Tumor in Nude Mice

Effects of Follicle Stimulating Hormone on Proliferation,Apoptopsis and Invasion of Immortalized Human Ovarian Epithelial Cells Through OCT4 Gene

[Effects of Follicle Stimulating Hormone on Proliferation, Apoptosis, Migration and Invasion of Ovarian Carcinoma Cells: an in Vitro Experiment].

VEGF-targeted short hairpin RNA inhibits intraperitoneal ovarian cancer growth in nude mice.

Dynamic progression of an intraperitoneal xenograft model of human ovarian cancer and its potential for preclinical trials

RNA interference targeting EGFR on proliferation of human ovarian carcinoma cell line SKOV_3

C57BL/6 mouse model of epithelial ovarian cancer and its biological characteristics

[Establishment and Comparison of Two Intraperitoneally Transplanted Human Ovarian Carcinoma Models with Immune Reconstitution in Severe Combined Immunodeficient Mice].

Effect of lentivirus mediated HER2-shRNA on chemosensitivity of human ovarian cancer SKOV3 cells

Research on the Impact of TRAIL on Apoptosis of SKOV3 Cell Line Ovarian Tumor Xenografts in Nude Mice

Study on the Inhibition of Small interfering RNA Targeting Osteopontin in the Human Ovarian Carcinoma SKOV3 Cells

ESTABLISHMENT OF TRANSPLANTABLE AND ASCITES MODELS OF HUMAN OVARIAN CARCINOMA IN NUDE MICE AND THEIR MORPHOLOGICAL CHARACTERISTICS